Skip to main content
. 2024 Apr 12;8(15):4223–4233. doi: 10.1182/bloodadvances.2024012798

Table 2.

Transplantation outcomes: engraftment and GVHD

De novo AML (n = 590) sAML (n = 129) P Overall (N = 719)
Engraftment
 Graft failure 66 (11.6%) 21 (16.5%) .13 87 (12.5%)
 Engrafted 502 (88.4%) 106 (83.5%) 608 (87.5%)
 Missing 22 2 24
Cumulative incidence of PMN > 500 88.2% [85.2-90.6] 83.3% [75.5-88.9] .042
aGVHD
 Grade 1 121 (21.3%) 22 (17.5%) ND 143 (20.6%)
 Grade 2 89 (15.7%) 13 (10.3%) 102 (14.7%)
 Grade 3 39 (6.9%) 5 (4%) 44 (6.3%)
 Grade 4 23 (4%) 7 (5.6%) 30 (4.3%)
 Present, grade unknown 3 (0.5%) 1 (0.8%) 4 (0.6%)
 No aGVHD present (grade 0) 293 (51.6%) 78 (61.9%) 371 (53.5%)
 Missing 22 3 25

Unless otherwise stated, results expressed as frequency (%); the numbers are the raw percentages for each grade GVHD.

ND, not done; PMN, polymorphonuclear neutrophils.